Some clinical and epidemiological studies suggest that anti-inflammatory agents can reduce the risk of certain types of cancer. For example, long-term use of low-dose aspirin has been shown to reduce the incidence of colorectal cancer and adenomatous polyps. However, the use of these agents as a preventive measure must be carefully weighed against potential side effects, such as gastrointestinal bleeding with NSAIDs.
